Ji Lin

2.0k total citations
50 papers, 1.1k citations indexed

About

Ji Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Ji Lin has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Physiology. Recurrent topics in Ji Lin's work include Statistical Methods in Clinical Trials (6 papers), Nutrition and Health in Aging (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Ji Lin is often cited by papers focused on Statistical Methods in Clinical Trials (6 papers), Nutrition and Health in Aging (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Ji Lin collaborates with scholars based in United States, China and United Kingdom. Ji Lin's co-authors include Robert H. Lyles, Lee‐Jen Wei, Xiaohong Chen, Jonathan R. Murrow, Nino Kavtaradze, Arshed A. Quyyumi, Ayaz Rahman, Amita K. Manatunga, Muhiddin Ozkor and Scott M. Hynes and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American Statistical Association.

In The Last Decade

Ji Lin

45 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ji Lin United States 19 380 352 233 160 143 50 1.1k
Kim Stuyckens United States 15 214 0.6× 340 1.0× 55 0.2× 245 1.5× 196 1.4× 26 929
J. W. Kugler United States 15 616 1.6× 188 0.5× 163 0.7× 152 0.9× 81 0.6× 32 1.1k
Nianping Hu Canada 11 123 0.3× 514 1.5× 71 0.3× 87 0.5× 191 1.3× 21 1.2k
John Simes Australia 11 179 0.5× 74 0.2× 149 0.6× 160 1.0× 275 1.9× 30 1.2k
Fangrong Yan China 20 254 0.7× 537 1.5× 40 0.2× 367 2.3× 121 0.8× 108 1.5k
Paula Curtis United Kingdom 12 75 0.2× 587 1.7× 129 0.6× 57 0.4× 266 1.9× 25 1.4k
Frans Van de Werf Belgium 8 313 0.8× 733 2.1× 133 0.6× 91 0.6× 666 4.7× 16 2.3k
William B. Wong United States 16 299 0.8× 115 0.3× 68 0.3× 284 1.8× 95 0.7× 65 892
Frank Pétavy Netherlands 19 202 0.5× 234 0.7× 153 0.7× 231 1.4× 194 1.4× 33 1.1k
Weichung Shih United States 17 142 0.4× 1.0k 3.0× 148 0.6× 465 2.9× 820 5.7× 31 2.8k

Countries citing papers authored by Ji Lin

Since Specialization
Citations

This map shows the geographic impact of Ji Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Lin more than expected).

Fields of papers citing papers by Ji Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Lin. The network helps show where Ji Lin may publish in the future.

Co-authorship network of co-authors of Ji Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ji Lin. A scholar is included among the top collaborators of Ji Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji Lin. Ji Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zheng, Jingwei, Dongze Wu, Xinxin Yang, et al.. (2025). Safety and feasibility of novel single-port robotic systems in colorectal cancer surgery: a comparative study with the da Vinci Xi system. International Journal of Colorectal Disease. 40(1). 236–236.
3.
Mi, Gu, et al.. (2024). A seamless phase II/III design with dose optimization for oncology drug development. Statistics in Medicine. 43(18). 3383–3402.
5.
Lin, Ray, Pralay Mukhopadhyay, Satrajit Roychoudhury, et al.. (2023). Comment on “Non-Proportional Hazards – an Evaluation of the MaxCombo Test in Cancer Clinical Trials” by the Cross-Pharma Non-Proportional Hazards Working Group. Statistics in Biopharmaceutical Research. 15(2). 312–314. 1 indexed citations
6.
Chen, Wei‐Sheng, Ji Lin, Weiteng Zhang, et al.. (2023). Effect of low-level creatinine clearance on short-term postoperative complications in patients with colorectal cancer. Journal of Gastrointestinal Oncology. 14(6). 2409–2424. 1 indexed citations
7.
Lin, Ji, Xingru Huang, Huiyu Zhou, Yaqi Wang, & Qianni Zhang. (2023). Stimulus-guided adaptive transformer network for retinal blood vessel segmentation in fundus images. Medical Image Analysis. 89. 102929–102929. 30 indexed citations
8.
Xu, Ke, Mingming Shi, Weiteng Zhang, et al.. (2021). Preoperative Fibrosis-4 (FIB-4) Evaluation May Be Helpful to Evaluate Prognosis of Gastric Cancer Patients Undergoing Operation: A Retrospective Study. Frontiers in Oncology. 11. 655343–655343. 5 indexed citations
10.
Lin, Ji, et al.. (2021). Electroacupuncture Attenuates Immune-Inflammatory Response in Hippocampus of Rats with Vascular Dementia by Inhibiting TLR4/MyD88 Signaling Pathway. Chinese Journal of Integrative Medicine. 28(2). 153–161. 12 indexed citations
11.
Lin, Ji, Weiteng Zhang, Wei‐Sheng Chen, et al.. (2019). Muscle Mass, Density, and Strength Are Necessary to Diagnose Sarcopenia in Patients With Gastric Cancer. Journal of Surgical Research. 241. 141–148. 15 indexed citations
12.
Bendell, Johanna C., Anna M. Varghese, David M. Hyman, et al.. (2018). A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer. Clinical Cancer Research. 24(14). 3253–3262. 81 indexed citations
13.
Zhang, Weiteng, Ji Lin, Wei‐Sheng Chen, et al.. (2018). Sarcopenic Obesity Is Associated with Severe Postoperative Complications in Gastric Cancer Patients Undergoing Gastrectomy: a Prospective Study. Journal of Gastrointestinal Surgery. 22(11). 1861–1869. 43 indexed citations
14.
Lin, Ji, Weiteng Zhang, Wei‐Sheng Chen, et al.. (2018). Sarcopenia is associated with the neutrophil/lymphocyte and platelet/lymphocyte ratios in operable gastric cancer patients: a prospective study. Cancer Management and Research. Volume 10. 4935–4944. 50 indexed citations
15.
Laquente, Berta, José A. López-Martín, Donald Richards, et al.. (2017). A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients. BMC Cancer. 17(1). 137–137. 53 indexed citations
16.
Hong, David S., Jeffrey R. Infante, Filip Jankú, et al.. (2016). Phase I Study of LY2606368, a Checkpoint Kinase 1 Inhibitor, in Patients With Advanced Cancer. Journal of Clinical Oncology. 34(15). 1764–1771. 118 indexed citations
17.
Calvo, Emiliano, Fadi Braiteh, Daniel D. Von Hoff, et al.. (2016). Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors. Oncology. 91(5). 251–260. 33 indexed citations
18.
Ozkor, Muhiddin, Ayaz Rahman, Jonathan R. Murrow, et al.. (2010). Abstract 13694: Greater Contribution of Endothelium-Derived Hyperpolarizing Factor to Exercise-Induced Vasodilation in African Americans Compared to Whites.. Circulation. 122. 1 indexed citations
19.
Ozkor, Muhiddin, Jonathan R. Murrow, Ayaz Rahman, et al.. (2010). THE CONTRIBUTION OF NITRIC OXIDE AND ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR TO RESTING AND STIMULATED VASODILATOR TONE IN AFRICAN AMERICAN AND WHITES. Journal of the American College of Cardiology. 55(10). A170.E1596–A170.E1596. 1 indexed citations
20.
Lyles, Robert H. & Ji Lin. (2010). Sensitivity analysis for misclassification in logistic regression via likelihood methods and predictive value weighting. Statistics in Medicine. 29(22). 2297–2309. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026